Search

everythinglearnresearchcommunity

for

Search:↓

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Tridax procumbens may boost the immune system.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

CMV infection increases the risk of GvHD after bone marrow transplants.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

Alopecia areata involves unique activation of certain immune cells.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Controlling immune responses with biomaterials can reduce scarring and improve skin regeneration.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Targeting specific T cells may help treat alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Tridax procumbens plant parts boost immune response in mice.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

NK cells play a role in skin diseases like eczema and psoriasis.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

CS12192 effectively treats alopecia areata with better safety than current options.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.